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Summary 
NIMA is essential for entry into mitosis in Aspergillus 
nidulans. To examine whether there is a NIMA-like 
pathway in other eukaryotic cell cycles, we expressed 
NIMA and its dominant negative mutants in two differ- 
ent eukaryotic systems. In Xenopus oocytes, NIMA in- 
duced germinal vesicle breakdown without activating 
Mos, CDC2, or MAP kinase. In HeLa cells, NIMA in- 
duced premature mitotic events without activating 
CDC2, whereas the mutants caused a specific G2 ar- 
rest but did not block mutant CDC2T14AYlS~-induced pre- 
mature entry into mitosis. A sequence essential for 
both these phenotypes was mapped to a region of 
100 amino acids lying just after the catalytic domain 
of NIMA that shows a significant similarity to protein 
interaction domains in other proteins. These results 
provide evidence for the existence of a NIMA-like mi- 
totic pathway in vertebrate cells. 
Introduction 
The CDC2 kinase associated with its cyclin partners has 
been shown to play an important role during G2/M progres- 
sion in eukaryotic ells (for review see Pines, 1993). How- 
ever, recent studies demonstrate that activation of the 
CDC2 kinase itself is not sufficient to trigger mitosis in 
some eukaryotic cells such as those in Saccharomyces 
cerevisiae (Amon et al., 1992; Sorger and Murray, 1992; 
Stueland et al., 1993) and Aspergillus nidulans (Osmani 
et al., 1991a). Furthermore, detailed analysis of mouse 
oocyte maturation reveals that CDC2 histone H1 kinase 
activity does not increase during the G2/M transition as 
indicated by germinal vesicle breakdown (GVBD) (Choi et 
al., 1991; Jung et al., 1993; Gavin et al., 1994). These 
results suggest that there might be other mitotic activation 
pathway(s) remaining to be identified. 
Recent studies have unveiled a mitotic kinase, NIMA, 
encoded by the Aspergillus nimA gene (Osmani et al., 
1988). Cells carrying temperature-sensitive mutations in 
nimA specifically arrest in G2 at the restrictive tempera- 
ture, although CDC2 is fully active, and rapidly and syn- 
chronously enter mitosis upon shift to the permissive tem- 
perature (Osmani et al., 1988, 1991a). NIMA kinase 
activity is tightly regulated during the nuclear division cy- 
cle, peaking in late G2 and M (Osmani et al., 1991b). Over- 
expression of NIMA promotes premature ntry of Aspergil- 
lus cells into M (Osmani et al., 1988; Lu and Means, 1994). 
Thus, NIMA is important for progression into mitosis in 
Aspergillus. 
NIMA is a protein-Ser/Thr kinase, biochemically distinct 
from other protein kinases, and its phosphotransferase 
activity is regulated by Ser/Thr phosphorylation (Lu et al., 
1993, 1994). While its physiological substrates have yet 
to be identified, NIMA cannot phosphorylate in vitro pro- 
teins or peptides that are good substrates for CDC2 (Lu 
et al., 1993, 1994). Optimal phosphorylation of peptide 
substrates by NIMA in vitro absolutely requires a Phe at 
position -3  on the N-terminal side of the phosphorylation 
site (Lu et al., 1994; Z. Songyang, K. P. L., T. H., and 
L. Cantley, unpublished data), which to date is a unique 
recognition sequence. In addition, the NIMA kinase con- 
tains an extended C-terminal noncatalytic domain. Ex- 
pression of this domain alone or of full-length kinase- 
negative NIMA produces a dominant negative phenotype, 
specifically arresting cells in G2 without affecting activa- 
tion of the endogenous NIMA and CDC2 in Aspergillus 
(Lu and Means, 1994). This suggests that the noncatalytic 
C-terminal domain may be essential for appropriate tar- 
geting of the NIMA kinase. Thus, NIMA is a mitotic protein 
kinase that is distinct from CDC2 but is also essential for 
entry into mitosis in Aspergillus. However, whether the 
NIMA pathway is restricted to the filamentous fungus 
A. nidulans or whether it is universal in all eukaryotic ells 
is unclear. 
To address this question, we have examined the effects 
of both wild-type and dominant negative mutant Aspergil- 
lus NIMAs on cell cycle progression in two different eukary- 
otic systems. Our results reveal the existence of a NIMA- 
like pathway required for the G2/M transition in vertebrate 
cells. 
Results 
NIMA Induces GVBD 
Since NIMA has mitosis-promoting activity in Aspergillus 
(Osmani et al., 1988, 1991a; Lu and Means, 1994), we 
first examined the ability of NIMA to promote entry into M 
in Xenopus laevis oocytes. To detect NIMA proteins, we 
inserted a FLAG epitope tag, which does not affect NIMA 
function in Aspergillus (Lu and Means, 1994), at the N-ter- 
minus of nimA cDNAs. Injection of RNAs encoding NIMA 
and a kinase-negative K40M NIMA mutant into oocytes 
led to the expression of -85  kDa NIMA proteins of the 
expected size (data not shown) (Lu and Means, 1994). 
To examine the effect of NIMAs on oocyte maturation, 
stage VI oocytes were injected with nimA RNAs and exam- 
ined for signs of maturation 12-14 hr later. As controls, 
oocytes were incubated with progesterone or injected in 
parallel with RNAs encoding Xenopus Mos or a kinase- 
negative K90R mutant. As shown previously (Freeman et 
al., 1990), both progesterone and mos RNA induced oo- 
cyte maturation characterized by white spot formation and 
GVBD, whereas mutant mos RNA had neither effect (Fig- 
ure 1A; data not shown). Wild-type nimA RNA induced 
pigment rearrangement at the animal pole and GVBD, as 
revealed by dissecting oocytes after fixation or serial sec- 
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Figure 1. NIMAInducesGVBDandPigmentRearrangementinXeno- 
pus Oocytes 
(A) Oocytes were injected either with water (control) or with 25 ng of 
the indicated RNAs or else incubated with progesterone for 12-16 hr, 
followed by examination of the pigment arrangement. 
(B) Oocytes were injected with water (control) or nimA RNA (NIMA) 
and 14 hr later were mbedded, followed by serial cryostat sectioning 
(30 p.m). After staining with propidium iodide, sections were examined 
by confocal microscopy. Magnification of upper and middle panels, 
5.5 x ; bottom panels, 34.7 x 
tioning, although there was not a typical white spot (Figure 
1A; data not shown); the mutantnimA RNA had no detect- 
able effect. Both the tagged and untagged NIMAs caused 
similar phenotypic hanges (Table 1). The NIMA-induced 
morphological changes (6-12 hr) were slightly slower than 
those with progesterone treatment (3-6 hr) and also de- 
pended on the RNA concentration used (Table 1; data not 
shown). 
To investigate the nature of the unusual NIMA-induced 
GVBD, serial cryostat sections were stained with propid- 
ium iodide and examined by confocal microscopy. In con- 
trol- or mutant nimA-injected oocytes, germinal vesicles 
were barely stained with propidium iodide, perhaps be- 
cause the chromatin was decondensed and thereby lost 
during sectioning (Figure 1B); in contrast, chromatin was 
condensed into individual chromosomes and moved to 
the surface of the animal cortex in progesterone-treated 
oocytes (data not shown). In nimA.injected oocytes, chro- 
matin was condensed, although it was not resolved into 
individual chromosomes and had not moved to the surface 
(Figure 1B), which might explain the atypical change in 
pigment granule distribution. Confocal microscopy of oo- 
cytes stained with anti-Xenopus tubulin antibodies re- 
vealed that the microtubule spindle was present in proges- 
terone-treated oocytes but not in nimA-injected oocytes 
(data not shown). Thus, NIMA induces nuclear envelope 
breakdown and chromatin condensation but not spindle 
formation or nuclear movement. 
NIMA Does Not Activate Mos, CDC2, or MAP 
Kinase in Xenopus Oocytes 
Since Mos, CDC2, and mitogen-activated protein (MAP) 
kinase are involved in oocyte maturation, we tested 
whether NIMA-induced GVBD might be mediated by any 
of these protein kinases. To examine the effect of NIMA 
on Mos synthesis, oocytes were injected with different 
RNAs or treated with progesterone, followed by immuno- 
precipitation using anti-Mos antibodies. A 3~S-labeled Mos 
protein of the expected size was detected in progesterone- 
treated and mos RNA-injected oocytes, but not in control 
oocytes (Figure 2A). However, we could not detect any 
Mos synthesis in oocytes that were injected with wild-type 
or mutant nimA RNA (Figure 2A), indicating that NIMA 
does not trigger synthesis of Mos. Furthermore, amos 
antisense oligonucleotide injected 4 hr prior to nimA did 
not prevent NIMA-induced GVBD, although it effectively 
prevented Mos synthesis (data not shown) and blocked 
progesterone-induced GVBD (Table 1), as shown pre- 
viously (Freeman et al., 1990). Thus, NIMA does not acti- 
vate the endogenous Mos-dependent pathway. 
CDC2 and p42 MAP kinase activity was assayed after 
nimA RNA injection, either by isolation with p13 beads or 
by anti-Xenopus p42 MAP kinase antibodies, respectively, 
or directly in whole-cell extract using histone H1 or myelin 
basic protein as substrates. Both procedures gave similar 
results (Figures 2B-2D). Progesterone treatment acti- 
vated both protein kinases at about the time the white spot 
appeared, and MAP kinase remained active throughout 
meiosis I and II, whereas CDC2 activity oscillated between 
meiosis I and II (Figures 2B and 2C). In contrast, neither 
protein kinase was activated in oocytes injected with nimA 
RNA either during or after NIMA-induced GVBD (Figures 
2B and 2C). Thus, NIMA-induced GVBD does not depend 
on either CDC2 or MAP kinase. 
To examine whether CDC2 and MAP kinase could still 
be activated in nimA-injected oocytes, progesterone was 
added to oocytes that were injected with nimA RNAs or 
water 12 hr before. Progesterone not only activated both 
CDC2 and MAP kinase and induced >90% GVBD in oo- 
cytes injected with water or mutant imA RNA, but also 
activated both protein kinases to the same extent in nimA- 
injected oocytes (Figure 2D); however, progesterone did 
not cause further detectable morphological changes (data 
not shown). Furthermore, coinjection of the wild-type, but 
not the mutant, nimA RNA with the activated phosphoryla- 
tion site mutant Xenopus CDC2 T14AY~SF RNA resulted in a 
reproducible increase in the rate of GVBD, characterized 
by white spot formation (data not shown). 
Expression of NIMA Causes Premature Mitotic 
Arrest in HeLa Cells 
To determine whether NIMA affected cell cycle progres- 
sion in mammalian cells, we chose the tTA-1 cell line, a 
HeLa cell derivative (Gossen and Bujard, 1992) that allows 
tetracycline-regulated transgene expression. To facilitate 
the identification of transfected cells and the localization 
of expressed proteins in cells, the FLAG epitope tag was 
inserted at the N-terminus of all nimA cDNAs. We at- 
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Table 1. Expression of NIMA Induces GVBD in Xenopus Oocytes 
Amount of RNA Total Number of Total Number of Percentage of Oocytes 
Treatment Injected (ng) Injected Oocytes Oocytes with GVBD with GVBD 
Control 
Progesterone 
Mos As plus progesterone 
NIMA 
FLAG-NIMA 
Mos As plus FLAG-NIMA 
K40M NIMA 
K40M FLAG-NIMA 
Mos 
K90R Mos 
31 0 0 
52 51 98 
13 2 15 
25 19 17 90 
25 65 60 92 
5 24 21 87 
1 20 14 75 
25 12 9 75 
25 20 1 5 
25 54 1 2 
15 22 0 0 
5 23 0 0 
25 47 45 96 
25 46 2 4 
(3.9) 
(7.4) 
(8.9) 
(9.6) 
Oocytes were injected with indicated amounts of various RNAs or incubated with progesterone and incubated overnight before fixation in 5% 
trichloroacetic acid for examining germinal vesicles. To reduce the endogenous Mos synthesis, a Mos antisense oligonucleotide (Mos As) was 
injected 4 hr before injection of N IMA or addition of progesterone. Numbers in parentheses indicate the time (hr) in which 50% of oocytes underwent 
GVBD in a representative experiment. 
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Figure 2. NIMA Induces GVBD in the Absence of Active Mos, CDC2, 
and MAP Kinase 
(A) Mos synthesis. Oocytes were injected with the indicated RNAs or 
with water (control) or were treated with progesterone a d labeled with 
tempted to establish stable cell lines expressing the NIMA 
protein, but had difficulty in obtaining G418- and hygro- 
mycin-resistant stable tTA-1 clones, even in the presence 
of the repressor tetracycline. The clones that survived id 
not express detectable NIMA, suggesting that NIMA has 
a toxic effect. Therefore, we resorted to using transient 
transfection of tTA-1 cells. 
The M2 antibody immunoprecipitated an -85  kDa pro- 
tein doublet from nimA-transfected 35S-labeled tTA-1 cells, 
but not from cells transfected with vector alone (Figure 
3A). Furthermore, NIMA kinase activity was detected in 
immunoprecipitates from nimA-transfected cells, but not 
from vector-transfected or untransfected cells (Figure 3B). 
In contrast, in the presence of tetracycline, NIMA protein 
was undetectable, and NIMA kinase activity was greatly 
reduced (Figure 3B). 
the ~S-Express label, followed byimmunoprecipitation, electrophore- 
sis, and autoradiography. Of the samples, one-fifth were loaded on 
Mos and its mutant lanes, with the position of Mos indicated. 
(B) CDC2 and MAP kinase activity after nimA injection. After nimA 
injection or progesterone treatment, oocytes were collected every 
2 hr, and CDC2 and MAP kinase were isolated using p13 beads and 
anti-p42 MAP kinase antibodies, respectively, followed by kinase 
assay using histone H1 and myelin basic protein assubstrates, respec- 
tively. 
(C) CDC2 and MAP kinase activity after NIMA-induced GVBD. Oocytes 
were injected with nimA RNA or incubated with (P) or without (C) pro- 
gesterone, and those undergoing pigment rearrangement (NIMA [A]) 
or white spot formation (progesterone [B]) werecollected (time 0) and 
then harvested after further incubation for the times indicated. CDC2 
and MAP kinase activities were directly assayed in oocyte extracts. 
The 0 and 120 rain timepoints indicate M1 and M2, respectively, for 
the hormone-treated oocytes. 
(D) CDC2 and MAP kinase activity after further treatment of NIMA- 
injected oocytes with progesterone. Oocytes wereinjected with nimA 
or K40M nimA RNA or with water (control). When NIMA induced >80% 
GVBD, progesterone was added 12 hr later to a fraction of oocytes 
in each group. Following 6 or 10 hr of additional incubation, CDC2 
and MAP kinase activities were assayed. 
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Figure 3. Tetracycline-Regulated ExpressionofNIMAandltsMutants 
in tTA-1 Cells 
Following transfection with the indicated expression vectors in the 
presence (plus) or absence (minus) of tetracycline (Tet), tTA-1 cells 
were either labeled with 35S-Express label, followed by immunoprecipi- 
tations using the M2 MAb, electrophoresis, and autoradiography (A), 
or directly subjected to immunoprecipitation, followed by kinase assay 
using PL1 peptide as a substrate (B). The positions of the various 
expressed proteins and molecular mass tandards are indicated. 
To examine the effect of NIMA on cell cycle progression, 
we used immunofluorescence microscopy to detect NIMA- 
expressing cells. M2-staining cells were undetectable in 
the presence of tetracycline, but were easily detected in 
its absence, corresponding to -10% of cells (data not 
shown). These results confirm that the M2 monoclonal 
antibody (MAb) is specific and that tetracycline regulates 
expression of NIMA. At 18 hr after transfection, NIMA ac- 
cumulated predominantly within nuclei, with nucleoli being 
stained less intensely, but there was some cytoplasmic 
staining. By 24 hr, - 90% of NIMA-expressing cells were 
rounded up, and NIMA was dispersed throughout the en- 
tire cell, with chromatin being in a compacted state com- 
pared with that in untransfected cells (data not shown). The 
microtubule network detected by tubulin immunostaining 
displayed a characteristic interphase array in most non- 
transfected cells, with the typical spindle in mitotic cells 
(data not shown). However, there was no mitotic spindle 
M2 Antibody DNA 
NIMA 
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Figure 4. Expression of NIMA or CDC2 "r14AYlSF Induces Condensation 
of Chromatin 
tTA-1 cells were transfected with NIMA (A and B) or Xenopus 
CDC2 T14AY15F (C and D) expression vectors for 24 hr, then fixed with 
formaldehyde, permeabilized with Triton X-100, and doubly labeled 
with the M2 MAb (A and C) and propidium iodide (B and D), followed 
by confocal microscopy using a 63x objective lens. Arrows point to 
M2-staining cells. 
in NIMA-expressing cells, and microtubules were concen- 
trated instead in a ring at the cell periphery (data not 
shown). Thus, NIMA induces chromatin condensation 
without mitotic spindle formation, a feature of premature 
chromatin condensation (Johnson and Rao, 1970). 
To examine the fine structure of the condensed chroma- 
tin, nucleoli, and the nuclear envelope and lamina, cells 
were stained with various antibodies, followed by confocal 
microscopy. Most nontransfected control cells displayed a 
normal interphase phenotype: nuclei were not condensed, 
with intact nucleoli readily identified by immunostaining 
using the nucleolar protein upstream binding factor anti- 
bodies (Figures 4A and 4B; data not shown); the lamina 
was typically located at the nuclear periphery (Figures 5A 
and 5B); and the nuclear envelope was intact as indicated 
by peripheral nuclear staining of p62 nucleoporin, a com- 
ponent of the nuclear pore complex (Figures 5G and 5H). 
However, -90% of NIMA-expressing cells were pheno- 
typically similar to premature mitotic cells. Chromatin was 
highly condensed into a wormlike structure wound around 
inside the cell (see Figures 4A and 4B), similar, but not 
identical, to the S premature chromosome condensation 
resulting from S and G2 cell fusion (Johnson and Rao, 
1970). p62 nucleoporin was dispersed throughout the cell, 
indicating nuclear membrane breakdown (Figures 5G and 
5H). The nuclear lamina was almost intact at the early 
stage of chromatin condensation, but decreased at the 
nuclear periphery as chromatin condensed further and ft. 
nally dispersed throughout the cell in a manner typical of 
untransfected mitotic cells (Figures 5C and 5D; data not 
shown). In addition, when cells were arrested in G1 before 
NIMA expression by the DNA synthesis inhibitor aphidi- 
colin or by the 3-hydroxy-3-methylglutaryl Coenzyme A 
reductase inhibitor Iovastatin, induction of NIMA expres- 
sion also resulted in chromatin condensation in - 90% of 
cells (data not shown). Furthermore, NIMA still induced 
the mitotic phenotype, even though cells were arrested 
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Figure 5. Expression of NIMA Induces Lamina Disassembly and Nu- 
clear Membrane Breakdown 
tTA-1 cells were doubly labeled 24 hr after transfection with the M2 
MAb (A, C, E, and G) and rabbit anti-lamin A antibodies (B, D, and F) 
or anti-p62 nucleoporin antibodies (H), followed by confocal micros- 
copy. (A) and (B) show an untransfected control cell; (C) and (D) show 
a NIMA-transfected cell; (E) and (F) show a CDC2 T~4AY~sF- transfected 
cell; (G) and (H) show NIMA-transfected (arrows) or untransfected 
cells. Magnification in (A)-(F), 44.0x; in IG) and (H), 27.7x. 
in G 1 or in G 1 and G2 by several different cyclin-dependent 
kinase (Cdk) inhibitors (see below). Collectively, these re- 
sults indicate that overexpression of NIMA in HeLa cells 
induces entry into a pseudomitotic state at all stages of 
the cell cycle. 
NIMA-Induced Premature Mitosis Does Not Depend 
on the Activation of the CDC2 Kinase 
in HeLa Cells 
To compare the NIMA phenotype with that resulting from 
expression of activated CDC2, a Xenopus CDC2 T~4AY~SF 
mutant with an N-terminal FLAG tag was expressed in 
tTA-1 cells in parallel with NIMA. As shown previously 
(Krek and Nigg, 1991), CDC2 T~4AY~SF induced premature 
mitotic events, including cell rounding, condensation of 
chromatin, dispersal of the nuclear lamina, breakdown of 
the nuclear membrane, and reorganization of the microtu- 
bule network into a ring (Figures 4C, 4D, 5E, and 5F; data 
not shown). These phenotypic changes were similar to 
those induced by NIMA, with two notable exceptions. The 
former induced condensation of chromatin into a looser 
and more spread structure when compared with NIMA 
(see Figure 4), and the CDC2T~4AY~F-induced effects were 
much slower, with ~ 20% of CDC2T~4AY~SF-expressing cells 
displaying the mitotic phenotype at 32 hr and -85% at 
48 hr (see Figure 8). This might be due to the fact that to 
promote entry into mitosis, the mutant CDC2 T14AY15F re- 
quires association with cyclin B, which also has to accum- 
ulate. 
Because NIMA and CDC2 T~4AY~SF induced a similar phe- 
notype, it was important o determine whether the NIMA 
effect was mediated by activation of the endogenous 
CDC2 in HeLa cells. To address this question, we used 
butyrolactone I, which is a specific inhibitor of Cdks, includ- 
ing CDC2, and which arrests cells in GI /S and G2/M (Kita- 
gawa et al., 1994). When tTA-1 cells were treated with 50 
or 100 p.M butyrolactone I, cell growth stopped within 12 
hr, and mitotic cells were barely detectable (data not 
shown). In contrast, neither 50 nor 100 ~M butyrolactone I 
affected NIMA-induced premature mitosis, when added 
at time 0 prior to detectable NIMA expression (Figure 6A). 
Butyrolactone I strongly inhibited cyclin B-CDC2 protein 
kinase activity, but had no effect on NIMA kinase activity in 
vitro (Figure 6C), confirming its specificity. Butyrolactone I 
inhibited phosphorylation of H1 in 32P-labeled cells, but 
not of several other acid-extracted proteins (Figure 6B), 
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Figure6. NIMA-Induced Premature Mitosis 
Cannot Be Blocked by Inhibition of Cdks 
(A) NIMA-induced premature mitosis. NIMA 
tTA-1 cells were either cotransfected with 
NIMA and p21 or p27 expression vectors or
transfected only with the NIMA expression vec- 
tor, but butyrolactone I (But) was added after 
removal of the calcium phosphate-DNA pre- 
cipitate. After staining with the M2 MAb and 
Hoechst dye, the percentage of cells with con- 
densed chromatin was scored. NIMAA344- 
395 was used as a control. At least 250 M2- 
positive cells were counted in random fields. 
(B) Histone H1 phosphorylation, tTA-1 cells 
were incubated with both [32P]orthophosphate 
and different concentrations of butyrolactone 
I for 8 hr. A histone-containing fraction wasprepared and separated with added commercial H1 by electrophoresis, followed by Coomassie staining 
(right) and autoradiography (left). 
(C) Effects of butyrolactone I on cyclin B-CDC2 and NIMA. Recombinant cyclin B-CDC2 and NIMA were incubated with different concentrations 
of butyrolactone I, followed by kinase assays using histone H1 and PL1 peptide as substrates, respectively. The activity in the absence of 
butyrolactone I was defined as 100%. 
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Table 2. A Small Domain Located after the Catalytic Domain Is Essential for Kinase-Active NIMAs to Induce Premature Mitosis 
Cells with Condensed 
NIMA Constructs Subcellular Localization Chromatin (%) 
Kinase Domain NLS 
NIMA ~" ," ~=~1 ---I I Nuclear 91.2 
1 B Xh N Xm 699 
NIMA491 ~ , ' iB - ' I I - - -  Nuclear 89.9 
491 
NIMA396 m ,'II-IB- Nuclear 43.8 
396 
NIMA344 m ~ Nuclear+cytosolic <10 
344 
NIMA~345-395 ~ Ill,,,,,/ Nuclear+cytosolic <10 
NIMA344-N m ~ Nuclear <10 
tTA-1 cells were transfected with DNA encoding NIMA mutants whose structures are shown, followed by immunoprecipitation to assay kinase 
activity of expressed proteins and by immunostaining to determine the protein localization and to score cells with condensation of chromatin. All 
the mutant proteins were active with similar specific activity. Open triangles, FLAG tag epitope; open rectangles, catalytic domain; closed squares, 
potential nuclear localization sequence; striated square, a nuclear localization sequence from SV40 large T antigen. Restriction enzymes used 
to make the mutants: B, BspEI; Xh, Xhol; N, Nrul; Xm, Xmnl. 
demonstrating that butyrolactone I indeed inhibited CDC2 
kinase in tTA-1 cells. Expression of p21 and p27, Cdk 
inhibitors that inhibit several Cdks in vitro and cause a G1 
arrest when overexpressed in vivo (Harper et al., 1993; 
Toyoshima and Hunter, 1994), induced a G1 arrest in tTA-1 
cells (data not shown), but neither substantially reduced 
nor delayed NIMA-induced chromatin condensation when 
coexpressed with NIMA (Figure 6A). In addition, NIMA and 
the nuclear lamina were dispersed throughout he entire 
cell (data not shown), indicating nuclear breakdown. Thus, 
the NIMA-induced pseudornitotic phenotype does not re- 
quire activation of the endogenous CDC2 kinase. 
A Small Domain Located after the Catalytic Domain 
Is Essential for the NIMA Function in HeLa Cells 
If NIMA induced mitosis in HeLa cells via a molecular 
mechanism similar to that in Aspergillus (Lu and Means, 
1994), the C-terminal noncatalytic domain should also be 
essential for NIMA to promote entry into mitosis in mam- 
malian cells. To test this hypothesis, four C-terminal trun- 
cations and one internal deletion were generated and 
transfected into tTA-1 ceils. All the mutant proteins were 
expressed at a level similar to or greater than that of the 
wild-type protein (see Figure 3A; data not shown) and had 
specific kinase activity similar to that of NIMA (data not 
shown). Although both NIMA491 (truncated at residue 
491) and NIMA396 (truncated at residue 396) accumulated 
predominantly within nuclei, -90% of NIMA491-expres- 
sing cells, but only -50% of NIMA396-expressing cells, 
displayed a pseudomitotic phenotype at 24 hr (Table 2). 
Truncation at residue 344 (NIMA344) resulted in some 
increase in cytosolic staining, and >90% of NIMA344- 
expressing cells displayed a typical interphase phenotype 
(Table 2). To circumvent potential problems with large 
truncations, an internal deletion, NIMAA344-395, lacking 
residues 344-395, was tested. NIMAA344-395 had pro- 
tein kinase activity and was partially nuclear (Table 2). 
Again, <10% of the transfected cells had condensed chro- 
matin (Table 2). Furthermore, cells expressing NIMA344 
or NIMAA344-395 progressed through mitosis normally, 
like untransfected cells (data not shown). Since residues 
345-395 contain a potential nuclear localization sequence 
(Table 2), we used the addition of a heterologous SV40 
large T antigen nuclear localization sequence to the 
C-terminus of NIMA344 (NIMA344-N) to test whether the 
inability of NIMA344 to induce entry into mitosis was due 
simply to a failure to accumulate in the nucleus. This mu- 
tant protein was found almost exclusively in the nucleus, 
as expected, but was still unable to promote entry into 
mitosis (Table 1). Thus, nuclear localization of kinase- 
active NIMA alone is insufficient o promote premature 
entry into mitosis, and the region containing residues 345- 
395 is required in addition. 
The Same Domain Located after the Catalytic 
Domain Is Also Essential for Dominant Negative 
NIMAs to Induce a Specific G2 Arrest in HeLa Cells 
Since the C-terminal domain was essential for NIMA- 
induced mitotic arrest (Table 2), this domain might exert 
a dominant negative phenotype in tTA-1 ceils, as is the case 
in Aspergillus (Lu and Means, 1994). To test this hypothesis, 
we expressed the kinase-negative full-length K40M NIMA, 
the N-terminal 280 residues (K40M280 NIMA), or the C-ter- 
minal 419 residues (NIMA280-699) in tTA-1 cells (see 
Figure 3; data not shown). Whereas K40M280 NIMA was 
cytosolic, both K40M NIMA and NIMA280-699 were 
predominantly nuclear, like wild-type NIMA (Table 3). Fur- 
thermore, cells expressing high levels of K40M NIMA or 
NIMA280-699, but not K40M280 NIMA, contained a large 
interphase nucleus (data not shown), suggesting that 
K40M NIMA and NIMA280-699 might induce a G2 arrest. 
To confirm this observation, ceils were transiently 
transfected for 48 hr and then doubly labeled with M2 MAb 
and propidium iodide, followed by fluorescence-activated 
cell sorter (FACS) analysis. The vector-transfected cells 
showed very little M2 staining, but cells transfected with 
different NIMA mutants displayed strong M2 staining (Fig- 
ures 7A-7D), consistent with results obtained by imrnuno- 
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Table 3. The Same Domain Located after the Catalytic Domain Is Also Necessary for Dominant Negative NIMAs to Induce a G2 Arrest 
Subcellular Changes in Cells 
DNA Constructs Localization with 4n DNA (%) 
Vector 100 
Kinase Domain NLS 
K40M NIMA ~' i ',; ~-~1 ~1 699 Nuclear 349.6 
1 K4OM B Xh N 
K40M396 NIMA ~, ~ Nuclear 235.6 
K,~OM 396 
K40M344 NIMA ~, ~ Nuclear+cytosolic 128.7 
K4OM 344 I 
K40M280NIMA ~ = , Cytosolic 127.6 
K4OM 280 
NIMA280-699 ¢x: ~ ~ Nuclear 347.2 
tTA-1 cells were transfected with DNA encoding NIMA mutants and stained with the M2 antibody, followed by immunofluarescence microscopy 
to determine the protein localization and by FACS analysis to determine cell cycle distribution, as described in Figure 7. The percentage of cells 
with 4n DNA content was determined in cells containing high levels of M2 staining, with total vector-transfected cells as control (100%). K40M, 
Lys-40 in the ATP-binding domain mutated to Met; the rest of the labels are the same as in Table 2, 
precipitation (see Figure 3A). The percentage of cells with 
4n DNA content was significantly increased in cells ex- 
pressing either K40M NIMA or NIMA280-699, as com- 
pared with control vector-transfected cells (Figure 7; Ta- 
ble 3). In cells with higher intensities of M2 staining, ~ 43% 
of cells were in G2, with commensurately fewer cells in 
G1 and S, whereas -20% of cells with low M2 staining 
were in G2. In contrast, cell cycle distribution was not sig- 
nificantly changed in cells expressing either low or high 
levels of K40M280 NIMA. Thus, expression of the NIMA 
C-terminal noncatalytic domain is both necessary and suf- 
ficient to induce a specific G2 arrest in a dose-dependent 
manner. 
To determine which region in the noncatalytic domain 
was required for the G2 arrest, different kinase-negative 
mutant NIMAs were generated and transfected into tTA-1 
cells. Both K40M396 and K40M344 NIMA proteins were 
predominantly located in the nucleus, although the latter 
had more cytoplasmic staining than the former (Table 3). 
Importantly, K40M396, but not K40M344, NIMA induced 
a G2 arrest (Table 3). Two smaller C-terminal fragments, 
NIMA280-491 and NIMA280-396, were also predomi- 
nantly localized in the nucleus, but, since the proteins were 
not expressed at high levels, probably owing to protein 
instability (data not shown), we could not determine their 
effects on cell cycle progression. Nevertheless, these re- 
sults are consistent with the fact that K40M344 NIMA is 
not dominant negative in Aspergillus (Lu and Means, 
1994), and indicate that the region containing residues 
345-396 is essential for the dominant negative phenotype. 
Dominant Negative NIMAs Do Not Block 
CDC2Tt4AVtS~-Induced Premature Entry 
into Mitosis 
As described above, CDC2 T14AY15F induces pseudomitotic 
events, but with slower kinetics than NIMA, with -20% 
displaying the mitotic phenotype at 32 hr and -85% by 
48 hr (Figure 8). If the CDC2 T~"AY~sF effects depended on 
activation of the potential endogenous NIMA pathway, 
dominant negative mutant NIMAs should block or at least 
delay the changes, since the dominant negative mutant 
NIMAs induced G2 arrest between 36 and 48 hr (see Fig- 
ure 7; data not shown). To examine this possibility, tTA-1 
cells were cotransfected with CDC2 T14AY15F and either 
A 
~o 
c 
c_ 
¢, 
Vector K40M NIMA 
4 R3 : , ," ,~  R3 
200 400 600 800 1000 
K40M280 NIMA 
_ 2 .  4n  
200 4O0 600 800 1000 
NIMA280-699 
200 400 600 8OO 1000 
DNA Content 
Increase in Cells 
with 4n DNA (%) DNA Cells in G2 (%) 
Vector 12.3 100.0 
K40M NIMA 
Low 19.6 159.3 
High 43.0 349.6 
K40M280 NIMA 
Low 13.6 110.6 
High 15.7 127.6 
NIMA280-699 
Low 21.6 175.6 
High 42,7 347.2 
Figure 7. Expression of the NIMA C-Terminal Noncatalytic Domain Is 
Bath Necessary and Sufficient to Induce G2 Arrest 
After transfection with various DNA expression vectors for 48 hr, tTA-1 
cells were stained with the M2 MAb and then with fluorescein isothiocy- 
anate-conjugated secondary antibodies and propidium iodide, fol- 
lowed by FACS analysis (A). Based on the fluorescein isothiocyanate 
intensity, cells were divided into two populations according ta low or 
high expression level, and cell cycle profiles were determined to com- 
pare with those in total vector-transfected cells (B). 
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Figure8. Dominant Negative Mutant NIMA Does Not Block 
CDC2T~4AYISF-Induced Premature Cell Rounding and Chromatin Con- 
densation 
tTA-1 cells were cotransfected with the indicated expression plasmids. 
At the times indicated, cells were fixed and doubly labeled with anti- 
Xenopus CDC2 antibodies and Hoechst dye, followed by scoring for 
the percentage of cells with rounding and chromatin condensation i  
at least 250 CDC2Tl~YlSF-expressing cells. 
NiMA280-699, NIMAA344-395, or control vector and 
then fixed at different imes after transfection, followed by 
immunostaining with antibodies against Xenopus CDC2 
and various other proteins. None of these cotransfected 
DNAs blocked or delayed CDC2 T~4AYlsF cell rounding and 
chromatin condensation (Figure 8), even though the mu- 
tant NIMAs were expressed about 10-fold higher than the 
mutant CDC2, as assayed by immunobloting analysis 
(data not shown). Furthermore, double staining with anti- 
Xenopus CDC2 and anti-lamin or anti-nucleoporin p62 an- 
tibodies revealed that CDC2 T14AYlsF still induced disassem- 
bly of the nuclear lamina and envelope with similar kinetics, 
despite expression of the dominant negative NIMAs (data 
not shown). Thus, the pseudomitotic phenotype induced 
by overexpression of CDC2 T~4AY15F is probably not the re- 
sult of activation of an endogenous NIMA pathway. 
Discussion 
This study demonstrates a specific requirement for a NIMA- 
like pathway for progression from G2 into mitosis in verte- 
brate cells. We base this conclusion on two types of re- 
sults. First, wild-type Aspergillus NIMA induced GVBD in 
Xenopus oocytes and promoted pseudomitotic events, in- 
cluding cell rounding, chromatin condensation, nuclear 
lamina disassembly, and nuclear membrane breakdown 
in HeLa cells in the absence of CDC2 activation. Second, 
dominant negative NIMA mutants induced a specific G2 
arrest in HeLa cells in a concentration-dependent manner, 
but did not block mutant CDC2-induced premature mito- 
sis. Thus, although overexpression of either NIMA or acti- 
vated CDC2 induces partially overlapping mitotic events, 
both NIMA and CDC2 pathways are required for normal 
mitotic progression. 
NIMA and GVBD during Oocyte Maturation 
NIMA induced GVBD, but not metaphase spindle forma- 
tion, nuclear movement, or a typical white spot. Coexpres- 
sion of NIMA with activated CDC2 accelerated the rate of 
normal white spot formation induced by the latter. These 
results suggest that some other factor(s) is required for 
nuclear movement and for white spot and metaphase spin- 
dle formation. Consistent with this, constitutively active 
protein kinase C or Ca2+/calmodulin-dependent protein ki- 
nase II can induce nuclear movement and white spot for- 
mation, but not GVBD (Muramatsu et al., 1989; Waldmann 
et al,, 1990), and the mitosis-specific MAb MPM2 inhibits 
white spot formation and GVBD with different potencies 
(Kuang et al., 1989). Thus, GVBD and white spot/spindle 
formation can be biochemically separated. In addition, 
GVBD can occur in mouse oocytes without active CDC2, 
which is activated much later, coincident with the forma- 
tion of the first metaphase plate (Choiet al., 1991; Jung 
et al., 1993; Gavin et al., 1994). Likewise, the Ser/Thr phos- 
phatase inhibitor okadaic acid blocks activation of histone 
H1 kinase and formation of the first metaphase plate, but 
not GVBD (Gavin et al., 1992, 1994). Thus, CDC2 might 
be responsible for the later steps during mouse oocyte 
maturation, such as the formation of metaphase spindle 
and white spot, leaving open the possibility that a NIMA- 
like kinase may be involved in GVBD. 
NIMA and the G2/M Transition in the Mitotic 
Cell Cycle 
Ectopic expression of wild-type NIMA induced premature 
mitotic events in HeLa ceils, whereas several other pro- 
tein-Ser/Thr kinases, including SRPK1, which is also ac- 
tive in mitosis (Gui et al., 1994), had no effect (K. P. L., 
X. D. Fu, and T. H., unpublished ata). Furthermore, dele- 
tion of just 50 residues from the noncatatytic domain com- 
pletely abolished the effects of NIMA. Thus, the ability of 
NIMA to promote premature entry into M is specific. In 
addition, while this paper was in revision, O'Connell et al. 
(1994) reported that NIMA induced premature chromatin 
condensation in fission yeast and HeLa cells, although 
they did not address whether a NIMA-like pathway is re- 
quired for the G2/M transition. 
Strong evidence for a requirement for a NIMA-like path- 
way for the G2/M transition comes from our experiments 
with kinase-negative mutant NIMAs. The NIMA C-terminal 
noncatalytic domain was both necessary and sufficient o 
induce a specific G2 arrest. The region containing resi- 
dues 345-396 was essential for the arrest and also for 
NIMA-induced premature mitosis. In addition, NIMA and 
NIMA280-396 were localized in the nucleus, consistent 
with NIMA having a nuclear function during mitosis. How- 
ever, the essential function of this region cannot be ex- 
plained by simply providing a nuclear localization se- 
quence. One explanation is that this region specifically 
recognizes a nuclear target for the endogenous NIMA-like 
kinase. 
This hypothesis is supported by a GenBank data base 
homology search in which only residues 310-400 out of 
the whole NIMA noncatalytic domain were found to have 
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significant similarity ( -  25% identity and - 55% similarity) 
to other proteins, which include caldesmon, trichohyalin, 
troponin T, and myosin heavy chain. Despite their diverse 
primary structures and cellular functions, all these proteins 
are involved in protein-protein interactions. All the NIMA- 
related domains are predicted to form a helical structure, 
and some of them are involved in binding other proteins 
or in protein oligomerization (for reviews see Korn and 
Hammer, 1988; Matsumura and Yamashiro, 1993; Titus, 
1993), suggesting that NIMA310-400 acts as either an 
association domain or a targeting sequence. 
NIMA310-400 might act as an auto-oligomerization do- 
main and increase activity (Lu and Means, 1994), but since 
all kinase-active NIMA proteins were fully active in HeLa 
cells and since the dominant negative NIMAs did not affect 
activity of NIMA either in vitro or in vivo, it is unlikely that 
NIMA310-400 has this function. Instead, we favor the idea 
that this region targets NIMA to the proper locale inside 
the nucleus, which could explain why the NIMA310-400 
domain is essential. Without his domain, the kinase-active 
NIMAs cannot be properly targeted and thereby cannot 
promote entry into M. On the other hand, the kinase- 
inactive mutants containing NIMA310-400 may act by 
competing with the endogenous NIMA for potential bind- 
ing sites and blocking the latter function. To arrest cells 
in G2, the dominant negative mutant NIMA would have 
to saturate all the binding sites, which would explain the 
strong concentration dependence of the dominant nega- 
tive mutants in both Aspergillus and HeLa cells. 
NIMA and CDC2 Mitotic Pathways 
NIMA and CDC2 show remarkable similarities in cell cy- 
cle-dependent function and regulation. For instance, their 
kinase activities are both regulated by protein phosphory- 
lation in a cell cycle-dependent manner. Furthermore, ec- 
topic expression of either active kinase promotes prema- 
ture entry into M (Osmani et al., 1988; Krek and Nigg, 
1991; Lu and Means, 1994), while either temperature- 
sensitive or dominant negative mutant NIMA or CDC2 
blocks cells in G2 (Osmani et al., 1988; Lu and Means, 
1994; Hamaguchi et al., 1992; van den Heuvel and Harlow, 
1993). However, the underlying mechanisms differ consid- 
erably. Whereas the activity of NIMA is controlled by the 
cell cycle-regulated expression of NIMA itself and by Ser/ 
Thr-phosphorylation (Osmani et al., 1991b; Lu et al., 
1993), CDC2 is regulated by Tyr- and Thr-phosphorylation 
as well as by association with its cyclin B partner (for review 
see Pines, 1993). The NIMA targeting sequence is proba- 
bly located in its own noncatalytic domain, whereas CDC2 
is targeted by its partners (Pines and Hunter, 1994). There- 
fore, although the regulatory mechanisms that govern the 
cell cycle-dependent abundance, activity, and localiza- 
tion of NIMA and CDC2 achieve the same end, they are 
largely intermolecular in CDC2 but intramolecular for 
NIMA. In addition, NIMA and CDC2 kinases have dramatic 
differences in their substrate specificity. CDC2 is a Pro- 
directed protein-Ser/Thr kinase requiring Pro at position 
+1 on the C-terminal side of the phosphorylation site (for 
review see Nigg, 1993), whereas NIMA absolutely requires 
Phe at position -3  (Lu et al., 1993, 1994; Z. Songyang, 
K. P. L., T. H., and L. Cantley, unpublished data). There- 
fore, it is unlikely that NIMA and CDC2 phosphorylate in 
vivo substrates at the same sites. 
In Aspergillus, CDC2 and NIMA are both normally re- 
quired for entry into mitosis (Osmani et al., 1991 a). In verte- 
brate cells NIMA and CDC2 induce partly overlapping sets 
of mitotic events. How are the CDC2 and NIMA pathways 
related? In HeLa cells neither chemical nor protein Cdk 
inhibitors blocked NIMA-induced mitotic events, indicating 
that the effects of NIMA are unlikely to occur because it 
is an upstream activator of CDC2. Conversely, dominant 
negative mutant NIMAs did not block or delay mitotic 
events induced by CDC2 T14A¥1~F, making it unlikely that 
CDC2 functions by activating the endogenous NIMA path- 
way. Although the mechanism through which dominant 
negative mutant NIMAs induce G2 arrest is not yet eluci- 
dated, the fact that it occurs in cells with a wild-type CDC2 
background indicates that there are interactions between 
these two pathways that coordinate entry into M. Such an 
interaction exists in Aspergillus, where CDC2-dependent 
progression into G2 is required for NIMA expression. In 
sum mary, our results in vertebrate cells are consistent with 
the findings in Aspergillus and indicate that both CDC2 
and NIMA pathways are normally required for entry into 
mitosis. 
NIMA-like Kinases in Mammalian Cells 
Given the evidence for a NIMA-like pathway in mammalian 
cells, is there a candidate NIMA-like protein kinase? Sev- 
eral mammalian NIMA-like kinase cDNAs have been iso- 
lated containing a catalytic domain related to that of NIMA 
(Letwin et al., 1992; Levedakou et al., 1994; Schultz et 
al., 1994; K. P. L. and T. H., unpublished ata). The mouse 
enzyme NEK1, like NIMA, is a basic protein and can phos- 
phorylate casein, but expression of NEK1 RNA is highly 
concentrated in germ cells, suggesting a role in meiosis 
(Letwin et al., 1992). Since NIMA could induce GVBD, 
NEK1 may be a specialized NIMA-like kinase involved in 
meiotic maturation. A second nimA-like cDNA is NLK1 
(K. P. L. and T. H., unpublished data) or NEK2 (Schultz 
et al., 1994). Like nimA, NLK1/NEK2 mRNA and protein 
levels are regulated in a cell cycle-dependent manner. 
However, its C-terminal noncatalytic domain is smaller and 
has little homology with NIMA. In addition, recombinant 
NLKI/NEK2 did not autophosphorylate, had very low ki- 
nase activity, and did not induce chromatin condensation 
when overexpressed in HeLa cells (K. P. L. and T. H., 
unpublished data). Since both phosphorylation and the 
C-terminal domain are essential for NIMA function (Lu et 
al., 1993; Lu and Means, 1994), NLKI/NEK2 may require 
additional regulatory modification or subunit(s). Finally, it 
should be noted that at least six complete or partial NLK 
cDNA clones have so far been isolated from human cells, 
suggesting that many NLKs exist in mammalian cells that 
may regulate different phases of the cell cycle or have 
specific functions in certain tissues. Characterization of 
different NLKs and their functions will be important for 
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unders tand ing  the role of  NIMA- l ike pathways  in mamma-  
l ian cells. 
Experimental Procedures 
Plasmid Constructions 
Xenopus mosXe/pSP64(polyA), mosX~9oRI/pSP64(polyA), and 
CDC2TI"A¥1SF/pSB5 were provided by D. Donoghue (University of Cali- 
fornia, San Diego; Freeman et al., 1990; Pickham et al., 1992). For 
synthesis of nimA RNAs, pGEX-A and pGEX-A(-) (Lu et al., 1993) 
were cut with Ncol and Hincll, blunt ended, and separately ligated 
into the Bglll of pSP64T vector. To insert the FLAG tag, NIMNpUHD- 
P1 and K40M/pUHD-P1 (Lu and Means, 1994) were digested with 
Nhel, blunt ended, and then cut with Xhoi, followed by ligating into 
Xhol and blunt-ended Ncol sites of NIMNpSP64T, respectively. 
For mammalian expression, NIMNpUHD-P1 and K40M/pUHD-P1 
were as described previously (Lu and Means, 1994). To generate the 
C- and N-terminal NIMA truncations, NIMNpUHD-P1 and K40M/ 
pUHD-P1 were digested with various enzymes (Table 2), which were 
blunt ended and then self-ligated with NIMA491 and K40M280 NIMA 
containing nine extra residues at the C-terminus. To insert the SV40 
large T antigen nuclear localization sequence at the C-terminus of 
NIMA344, NIMNpUHD-P1 was digested with Xbal and Xhol and then 
ligated with an oligonucleotide ncoding LD, APKKKRKV. For expres- 
sion of the mutant CDC2, Xenopus CDC2 T14A¥1sF (Pickham et al., 1992) 
was digested with Hindlll, blunt ended, and then digested with BamHI, 
followed by ligation into BamHI and blunt-ended EcoRI sites of pUHD- 
P1 with the FLAG epitope tag at the N-termlnus. To express p21 and 
p27, human p21 in a Ncol fragment (provided by R. Poon) was sub- 
cloned into the Ncol site of pUHD-P1, while p27 was in a pCMX vector 
(-royoshima nd Hunter, 1994). All constructs were sequenced across 
the ligation points to confirm the open reading frame. 
In Vitro RNA Synthesis and Oocyte Microinjection 
RNAs were synthesized using SP6 polyn~erase and translated in vitro 
to confirm that RNAs were translated into protein s of the expected 
sizes. Stage VI Xenopus oocytes were microinjected with 50 nl of RNA 
or control water. Microinjected oocytes were incubated in MBSH at 
room temperature or 18°C and scored for GVBD by the appearance 
of a white spot (Merriam, 1971) or by the alteration of pigmentation 
for NIMA. To confirm GVBD, oocytes were fixed in 5o/o trichloroacetic 
acid and manually dissected or serially sectioned after embedding. 
Progesterone (5 p.g/ml), Xenopus rods RNA, and K90R mos RNA were 
used as controls. 
To examine the chromatin structure, oocytes were embedded in 
gelatin, cryostat sectioned (30 ~m thick) as described previously (Hu- 
chon et al., 1993), and examined by an MRC-600 laser-scanning confo- 
cal assembly (Bio-Rad) after staining with propidium iodide (100 t~g/ 
ml). The microtubule spindle was examined as described previously 
(Gard, 1993) using anti-Xenopus tubulin antibodies (gift of C. Jessus, 
Centre National de la Recherche Scientifique; Huchon et al., 1993). 
DNA Transfections 
The tTA-1 cell line (gift of H. Bujard, University of Heidelberg; Gossen 
and Bujard, 1992) was maintained in DMEM supplemented with 10O/o 
fetal serum and 500 pg/ml G418. Calcium phosphate transfections 
were carried out as described by'Chen and Okayama (1987). Time 0 
is defined as the moment when the calcium phosphate precipitate 
was removed. Tetracycline (2 p_g/ml) was used to repress transgene 
expression (Gossen and Bujard, 1992). 
indirect Immunoffuorescence Microscopy 
Transfected cells were fixed with 3% formaldehyde, 2% sucrose in 
PBS for 5 rain (Nigg et al., 1985) and subjected to i mm unofluorescence 
microscopy as described (Molloy et al., 1994). Cells were postfixed 
with methanol to stabilize tubulin (Krek and Nigg, 1991). The dilution 
of primary antibodies was as follows: mouse M2 MAb (Kodak/IBI), 
1:800; affinity-purified anti-Xenopus CDC2 C-terminal antibodies (gift 
of J. Newport, University of California, San Diego), 1:1500; guinea pig 
anti-Xenopus tubulin antibodies (gift of C. Jessus, Centre National de 
la Recherche Scientifique; Huchon et al., 1993), 1:600; mouse and 
rabbit anti-lamin antibodies (gift of L. Gerace, Scripps Research Insti- 
tute) and human anti-rRNA transcription upstream binding factor anti- 
bodies (gift of E. Chan, Scripps Research Institute; Chan et al., 1991), 
1:200; mouse and rabbit anti-p62 nucleoporin antibodies°(gift of D. 
Forbes, University of California, San Diego; Finlay et.al., 1991), 
1:10,000 and 1:50, respectively. Cells were stained with appropriate 
secondary antibodies and Hoechst dye 33258 or propidium iodide 
(100 p.g/ml), observed, and photographed with a Zeiss microscope or 
MRC-600 or MRC-1000 laser-scanning confocal assembly (Bio-Rad). 
Flow Cytometry Analysis 
Ceils were harvested 48 hr after transfection and fixed with ice-cold 
70% ethanol at least overnight. Cells were stained with the M2 MAb 
and fluorescein-conjugated goat anti-mouse IgG, followed by staining 
with propidium iodide, as described previously (Zhu et al., 1993). Flow 
cytometry analysis was performed on a Becton-Dickinson FACScan 
machine. About 5 x 10 ~ to 10 x 103 total and M2-positive cells were 
collected to determine the DNA content, and cell cycle profiles were 
determined using the M Cycle analysis software. 
Metabolic Labeling, Immunoprecipitation, 
and Phosphoprotein Analysis 
Mos protein was detected using anti-Mos x~ antibodies (provided by D. 
Donoghue, University of California, San Diego; Freeman et al., 1990). 
NIMA proteins were detected using the M2 MAb. For in vivo labeling 
of tTA-1 cells, after removing the calcium phosphate-DNA precipitate, 
cells were refed with normal growth medium for 12 hr and then incu- 
bated in Met-Cys-free DMEM containing 10% dialyzed fetal serum 
and in 0.1 mCi/ml mS-Express label for 12 hr. Cells were washed and 
lysed in RIPA buffer, followed by immunoprecipitation. To measure 
in vivo histone H1 phosphorylation, we incubated tTA-1 cells with 
1 mCi/m132p and different concentrations of butyrolactone I (provided 
by A. Okuyama, Banyu Pharmaceutical Company; KitagaWa et al., 
1994) for 8 hr, followed by analysis of H 1 phosphorylation as described 
(Kitagawa et al., 1994). 
NIMA, CDC2, and MAP Kinase Assays 
To assay CDC2 and MAP kinase in oocytes, we lysed 5-10 oocytes 
in 100-200 I11 of lysis buffer (20 mM HEPES [pH 7.5], 80 mM ~-gly- 
cerophosphate, 15 mM MgCI2, 20 mM EGTA, 50 mM NaF, 1 mM 
Na3VO4, 50 I~g/ml PMSF, 10 p.g/ml leupeptin, 10 i~g/ml aprotinin, 10 
pM pepstatin, and 1 mM DTT). CDC2 and p42 MAP kinase were iso- 
lated from the lysates using p13 beads and anti-Xenopus p42 MAP 
kinase antibodies (Hsiao et al., 1994), respectively, followed by kinase 
assays as described below. Alternatively, 10 p,I of clarified lysate was 
added directly to kinase buffer (40 mM HEPES [pH 7.5], 10 mM EGTA, 
10 mM MgCI2, 5 p,M protein kinase A inhibitor, 100 p_M ATP, 0.5 Id of 
[y-32P]ATP [Amersham], 1 mM DTT, and 0,1 p~g/ml histone H1 [Sigma] 
for assaying CDC2 H1 kinase or 0.5 rtg/ml myelin basic protein [Sigma] 
for assaying MAP kinase). After 10 rain at 30°C, reactions were 
stopped and analyzed by electrophoresis and autoradiography. 
Kinase activity of expressed NIMAs was assayed using the PL1 
peptide (DEEEGTFRASIRLAARR) as a substrate after immunoprecipi- 
tation (Lu et al., 1994; Lu and Means, 1994). The effects of butyrolac- 
tone I on recombinant cyclin B-CDC2 and NIMA were assayed using 
histone H1 and PL1 peptide as substrates, respectively (Lu et al., 
1993). 
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Note Added in Proof 
Ye et al. have recently reported an example of the possible interaction 
between CDC2 and NIMA pathways in Aspergillus nidulans: Ye, X. S., 
Xu, G., Pu, R. T., Fincher, R. R., McGuire, S. L., Osmani, A. H., and 
Osmani, S. A. (1995). The N I MA protein kinase is hyperphosphorylated 
and activated ownstream of p34 ~2 cyclin B: coordination of two mito- 
sis promoting kinases. EMBO J. 14,986-994. Although CDC2 is not 
required for N IMA to promote ntry into mitosis, it induces phosphoryla- 
tion of NIMA on MPM2 epitopes at M phase, resulting in a small in- 
crease in NIMA kinase activity. 
